top of page

Pharmac - Supply Update

ree

In this issue


New medicine supply notices


Fulvestrant: Your brand is changing The funded brand of fulvestrant is changing from Faslodex to Fulvestrant EVER Pharma. Fulvestrant EVER Pharma will be listed from 1 December 2025. Faslodex will be delisted 1 May 2026. A patient flier is available to support the brand change.


Paxlovid pharmacy-initiated supply


Use the Pharmacode 2714647 to claim for the pharmacist consult when dispensing supplier-owned stock.

The subsidy for this fee shows on the Pharmaceutical Schedule as zero. This is because Pharmac does not pay for this service, Health NZ will reimburse this fee to pharmacies. This Pharmacode will trigger payment from Health NZ.


Updated medicine supply notices


Codeine (15 mg, 30 mg, 60 mg tablets): Stock of 15 mg and 60 mg codeine tablets is available for wholesalers to order again this week. This stock has been over-labelled with a new expiry date. A patient flyer is available with more information. Imiquimod: Supply issue and new look (Pharmacode: 2543907) The supplier has run out of imiquimod until the new look product arrives. It will be available again late November 2025. Laxsol is changing to Solax Solax will be listed 1 December 2025. Laxsol will be delisted 1 May 2026. A patient flyer is available to support discussions about this brand change.Methylphenidate Supplier stock holdings as at 14 November 2025. 


  • Concerta: All strengths available


    Ritalin: All strengths available


    Rubifen: All strengths available, except 20 mg immediate release


    Teva: All strengths available, except 27 mg.


There has been a brief delay on the arrival of the new brand of methylphenidate, Methylphenidate Sandoz XR, which is funded from 1 December 2025.



The following products are out of stock at Nutricia:


  • Fortisip Compact Protein - Vanillla flavour (Pharmacode: 2644711) 

  • HCU Lophlex LQ Juicy Berries (Pharmacodes 2592096 or 2683008)

  • Liquigen (Pharmacode 2441241)

  • Loprofin rice pasta (Pharmacode: 2218259)

  • Loprofin spaghetti (Pharmacode 475963


Oestradiol patches From 1 December 2025, Estradiol TDP Mylan and Estradot will be the funded brands of oestradiol patch. A brand switch fee will also apply from 1 December 2025 until 28 February 2026. Pharmacies, GPs, and other health professionals can order printed flyers to support conversations with people affected by this change. Bluestar order form for A5 patient fliers  


Pregabalin: Brand change to Lyrica Everyone should now have moved to Lyrica. A brand switch fee will apply from 1 March 2026 until 1 July 2026. We will send a reminder closer to the time for the brand switch fee. 


Rosuvastatin (10 mg, 20 mg, 40 mg tablets) We have funded an alternative from 11 November 2025. It will be available from Sandoz from mid-November 2025.


Sodium chloride (Biomed) nebulising solution 7%, 90 ml Stock of sodium chloride is available from the supplier again. It may take 1 or 2 weeks to reach pharmacies around the country.


Tender brand change for cefalexin


1 December 2025 | Cefalexin Lupin 250 mg and Cefalexin Sandoz 500 mg will be listed on the Pharmaceutical Schedule.


1 May 2026 | Cephalexin ABM 250 mg (Pharmacode: 2498871) and Cephalexin ABM 500 mg (Pharmacode: 2361248), supplied by Boucher & Muir, will be delisted from the Pharmaceutical.


The Cefalexin Lupin 250 mg and Cefalexin Sandoz 500 mg will be the Principal Supply Status from 1 May 2026.


Resolved issues


Note: Supply issues are marked as resolved one week after when the supplier has product available. It can take another 1 to 2 weeks for stock to reach pharmacies around the motu.


Recent decisions and open consultations





2025/26 Invitation to Tender (Closes 15 December 2025)


Monthly updates









bottom of page